Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD (Q85645457)
Jump to navigation
Jump to search
scientific article published on 08 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD |
scientific article published on 08 December 2012 |
Statements
Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD (English)
Rodger Kempsford
Virginia Norris
8 December 2012